The Society for Clinical Research Sites (SCRS) is launching the Site Advocacy Group (SAG) initiative, partnered with TransCelerate BioPharma.

The SAG is a landmark industry initiative that enables clinical investigators and site professionals to interact directly with senior industry leaders to exchange perspectives and experiences on innovative ideas, processes, tools and technologies. The knowledge gained will help to promote site sustainability, enhance clinical research effectiveness and more closely align the work of the sites and industry across the research ecosystem.

"By bringing together the global site community, SCRS has actively advocated for the sustainability of all sites. The formation of the SAG is the most recent example," said Christine Pierre, president of SCRS. "It marks a true coalescence of major industry stakeholders working together toward mutually beneficial and respectful outcomes with the sites. This commitment by TransCelerate, representing 19 major sponsors, demonstrates a true commitment to the site community."

SCRS members representing a broad spectrum of site professionals and clinical research sites will partner with TransCelerate workstream members to exchange practical feedback on various topics. In return, industry leaders will share with the sites their key priorities and initiatives to elevate the ecosystem.

"TransCelerate is thrilled to partner with SCRS, a global organization created by the investigator community to advocate for the investigator community," said Dalvir Gill, Ph.D., CEO of TransCelerate. "This SAG program will provide TransCelerate workstreams direct access to the voice of investigative sites around the world, gather timely input and feedback on projects and further optimize the impact we can make on clinical trials efficiency."

Moving forward, outcomes from the SAG initiative will help to inform collaborative initiatives within the industry aimed at enhancing safety, efficiency and innovation. Results from the SAG initiative also can enhance operational and business performance for sites.